Accolade
accolade.com
Actively hiring
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$568.7M
6 rounds on record
Latest round
$11.3M
Venture round · Sep 2021 · 5 yr ago
Team
1,810
US Form 5500 (plan participants) · Dec 2024
Backers
2
Comcast Ventures, Madrona
The money's age
Long since its last round
60 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 30, 2021
Raised a round Venture round $11.3M · SEC Form D
Jun 9, 2021
Raised a round Venture round $325.3M · SEC Form D
Mar 3, 2021
Raised a round Venture round $130M · SEC Form D
Oct 2, 2019
Raised a round Venture round $20M · SEC Form D
Mar 16, 2018
Raised a round Venture round $27.2M · SEC Form D
Jul 26, 2016
Raised a round Venture round $55M · SEC Form D
Tractionpublic signals, read monthly
Web presence
top 0.06%
of 133.2M domains by links, Common Crawl
App Store
4.8 ★
45k ratings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2021 | $11.3M | — | SEC Form D |
| Venture round | Jun 2021 | $325.3M | — | SEC Form D |
| Venture round | Mar 2021 | $130M | — | SEC Form D |
| Venture round | Oct 2019 | $20M | — | SEC Form D |
| Venture round | Mar 2018 | $27.2M | — | SEC Form D |
| Venture round | Jul 2016 | $55M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Transcarent, Inc. | its site |
Founders and leadersfrom filings, registers and the company's site
Thomas SpannExecutive Officer, DirectorSEC Form D
Stephen BarnesExecutive OfficerSEC Form D
Rajeev SinghExecutive Officer, DirectorSEC Form D
Robert CavanaughExecutive OfficerSEC Form D
Ivor HornExecutive OfficerSEC Form D
Dave SwiftExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Comcast Ventures 
Madrona Similar startupsby what they do, their industry and backers
Healthcare can be complicated. Payors, Provider Organizations, and, most importantly, patients deserve a partner who makes it easier. Arkos…
Corporate gifting, the way it should be. Brilliant delivers full-service creative, a powerful platform, and hassle-free global fulfillment…
Givers enrolls, supports, and pays family caregivers through state programs so they can focus on what truly matters—caring for their loved…
Life's too complicated, your energy drink shouldn't be. Zero sugar and 5 super ingredients.
Plinto is the the AI assistant for effortless financial controlling. Financial controlling shouldn’t be a month-end fire drill, it should…
Drayage doesn't have to be complicated. We offer the flexibility of a freight broker with the accountability of a trucker.
News
Report
Digital health startup Transcarent takes Accolade private in $621 million deal
Transcarent CEO Glen Tullman previously led Livongo, which was purchased by Teladoc in a 2020 agreement that valued the company at$18.5 billion.
Read more
Report
German startup wins accolade for its fusion reactor design
ProximaFusion, a two-year-old German nuclear fusion startup, has published plans for a working fusion power plant in a peer-reviewed journal, in what is
Read more
Report
Accolade Gets a Do-Over With Transcarent's $621M Acquisition
Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say.
Read more
Report
Transcarent to acquire Accolade for $621 million creating benefits tech giant
Transcarent on Wednesday said it was buying Accolade, a health benefits company, for $621 million, offering a significant premium on Accolade's share price.
Read more
Report
Transcarent to Acquire Accolade in $621M Deal - Health M&A
Transcarent will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash totalling $621M.
Read more
Report
Why Shares of Accolade Fell This Week
The company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.
Read more
Report
Show more news
People
Thomas Spann
Executive Officer, Director
Stephen Barnes
Executive Officer
Rajeev Singh
Executive Officer, Director
Robert Cavanaugh
Executive Officer
Ivor Horn
Executive Officer
Dave Swift
Executive Officer
Elizabeth Napolitano
Executive Officer
Richard Eskew
Executive Officer
Mike Hilton
Executive Officer
Michael Hilton
Executive Officer
Jeff Jordan
Director
Mark Mactas
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Plymouth Meeting
United States
HQ
1000-5000 est. staff
Financials
Total raised
$568.7M
Latest round
Venture - Series Unknown
Funding rounds
6
Funding rounds